Couttas TA, Hoffmann AE, Jieu B, Golla FR, Shepherd CE, Leweke FM, Rohleder C. Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders. Transl Psychiatry. 2026 16(1)
Dammann-Bawadkji I, Leweke FM, Rohleder C. Animal Models for Drug Discovery in Schizophrenia: A Critical View from a Clinical Perspective. Pharmaceut Med. 2026 Jul 14. [Epub ahead of print]
Volkmer S, Kubera KM, Fritze S, Brandt G, Akkoc Altinok DC, Daub J, Kukovic J, Böttcher KT, Berhe O, Lin Y, Tost H, Marquand AF, Meyer-Lindenberg A, Schwarz E, Hirjak D. Normative age-related structural brain deviations underlying psychopathology, cognitive impairment and neurological soft signs in schizophrenia spectrum disorders. Transl Psychiatry. 2026 16(1):197. Epub 2026 Mar 20.